Human Metabolome Technologies (TSE:6090) Institutional Ownership: 0.09% (As of Aug. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6090 Human Metabolome Technologies Inc TSE:6090
52 GF Score
Price 円600.00
GF Value 円799.20
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Human Metabolome Technologies Institutional Ownership?

Human Metabolome Technologies TSE:6090 -0.66% 52 Institutional Ownership is 0.09% as of Aug. 14, 2026. GuruFocus rates TSE:6090 with a GF Score™ of 52/100 and a GF Value™ of 円799.20 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Human Metabolome Technologies's institutional ownership is 0.09%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Human Metabolome Technologies's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Human Metabolome Technologies's Float Percentage Of Total Shares Outstanding is 0.00%.

Human Metabolome Technologies Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Human Metabolome Technologies's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Human Metabolome Technologies Institutional Ownership Chart

Human Metabolome Technologies Historical Data

The historical data trend for Human Metabolome Technologies can be seen below:

2021-10-31 2021-11-30 2021-12-31 2022-01-31 2022-02-28 2022-03-31 2025-03-31 2025-04-30 2025-05-31 2025-06-30
Institutional Ownership 0.26 0.05 0.05 0.05 0.05 0.01 0.16 0.16 0.16 0.09
TSE:6090
52GF Score
Human Metabolome Technologies Inc TSE:6090
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Human Metabolome Technologies Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.09% mean?
Human Metabolome Technologies (TSE:6090) has a Institutional Ownership of 0.09% as of Aug. 14, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Human Metabolome Technologies and its competitors.
Is Human Metabolome Technologies' Institutional Ownership too high?
Human Metabolome Technologies' current Institutional Ownership is 0.09%. Overall, Human Metabolome Technologies has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Human Metabolome Technologies' Institutional Ownership compare to TMO and DHR?
Human Metabolome Technologies' Institutional Ownership of 0.09% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Diagnostics & Research company?
A good Institutional Ownership depends on the Medical Diagnostics & Research industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Human Metabolome Technologies and its competitors. Human Metabolome Technologies's current Institutional Ownership is 0.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Human Metabolome Technologies stock overvalued right now?
Based on GuruFocus' analysis, Human Metabolome Technologies (TSE:6090) is currently considered Modestly Undervalued. The stock's GF Value™ is 円799.20, compared to a current price of 円600.00 — trading 24.9% below its estimated fair value. The current Institutional Ownership is 0.09%. Human Metabolome Technologies' overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Human Metabolome Technologies (TSE:6090), the current Institutional Ownership is 0.09% as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Human Metabolome Technologies (TSE:6090) Overvalued in 2026?

Based on GuruFocus' analysis, Human Metabolome Technologies stock appears to be undervalued. The current stock price of 円600.00 is trading 24.9% below its estimated GF Value™ of 円799.20. GuruFocus considers Human Metabolome Technologies to be Modestly Undervalued.

Key valuation signals for TSE:6090:

  • Institutional Ownership: 0.09%
  • GF Value™: 円799.20 vs. price of 円600.00 (24.9% below fair value)
  • GF Score™: 52/100 with 5 warning signs

No single metric tells the full story. See the TSE:6090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Human Metabolome Technologies Business Description

Address Yamagata Prefecture Kakuganji Water 246-2, Tsuruoka, JPN, 997-0052
Human Metabolome Technologies Inc is involved in the search and diagnosis of biomarkers and commercialization in the field of drug development.
52GF Score

Get the complete analysis for TSE:6090

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円600.00
Price
円799.20
GF Value